International Stroke Conference 2009. Translation of high impact targets into clinical trials. 17-20 February 2009, San Diego, CA, USA.
Tymianski
Michael
M
Toronto Western Hospital Research Institute, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada. mike_t@uhnres.utoronto.ca
D000818:Animals; D002140:California; D002986:Clinical Trials as Topic; D015195:Drug Design; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008911:Minocycline / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011994:Recombinant Proteins; D020521:Stroke / Q000188:drug therapy* / Q000378:metabolism; D016896:Treatment Outcome
D018696:Neuroprotective Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D008911:Minocycline